GleamWall
中文EN

MEHA Functional Brands Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1837254 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.1%
TTM net income YoY-2,452.2%
TTM EPS YoY-340.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin55.8%
Operating margin-51.8%
Net margin-142.5%
FCF margin—
EBITDA margin-51.6%

Returns

ROE—
ROA-132.2%
ROIC (approx.)—
Asset turnover0.93x

Leverage & solvency

Liabilities / assets160.0%
Debt / equity—
Current ratio0.30x
Interest coverage-7.66x

Cash quality & payout

Operating cash flow / net income0.40x
Accruals ratio-79.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.65M$1.87M$1.65M$1.49M$1.69M$1.83M$1.59M$1.68M
Cost of revenue$684,289$750,207$684,391$823,766$715,824$864,437$723,492$690,623
Gross profit$960,764$1.12M$961,133$670,755$978,350$968,095$866,764$989,473
SG&A expense$1.08M$2.10M$1.38M$1.63M$937,762$958,493$720,234$1.00M
Operating income-$314,762-$1.32M-$682,805-$1.13M-$78,288-$155,437-$32,100-$135,747
Interest expense$246,165$97,801$25,804$80,981$155,310$71,012$95,094$142,284
Net income-$714,455-$2.63M-$6.99M$852,315$259,001-$226,056-$126,782-$277,750
EBITDA-$310,369-$1.32M-$678,223-$1.13M-$73,346-$149,212-$25,875-$127,952
EPS (basic)-0.01-0.06-0.36—0.04-0.03-0.02—
EPS (diluted)-0.01-0.06-0.36—0.04-0.03-0.02—
Weighted avg. shares (diluted)64.92M42.67M19.59M—7.20M6.95M6.92M—
Balance sheet
Cash & equivalents$231,900$352,142$1.08M$2.73M$1.01M$257,682$213,631$211,642
Receivables$298,965$503,440$372,712$518,474$89,213——$303,471
Inventory$1.71M$1.68M$1.59M$1.55M$1.69M——$1.71M
Current assets$2.51M$2.74M$3.40M$5.19M$4.21M——$2.86M
PP&E, net$23,890$28,283$32,797$37,379$42,086——$49,564
Goodwill$818,139$818,139$818,139$818,139$818,139——$818,139
Intangibles$1.36M$1.37M$1.39M$1.40M$1.41M——$1.44M
Total assets$6.12M$6.45M$7.21M$9.11M$8.23M——$7.17M
Current liabilities$8.32M$5.65M$2.84M$5.75M$5.70M——$5.20M
Short-term debt———$154,957————
Long-term debt$137,780$138,680$139,571$140,468$141,327———
Total debt$137,780$138,680$139,571$295,425$141,327———
Total liabilities$9.78M$9.41M$11.72M$7.57M$7.63M——$7.29M
Shareholders' equity-$3.67M-$2.96M-$4.51M$1.54M$604,665$257,164$153,013-$118,577
Net debt-$94,120-$213,462-$938,396-$2.43M-$863,997———
Shares outstanding64.92M64.92M21.35M18.70M7.08M——6.69M
Cash flow statement
Operating cash flow-$74,755-$518,898-$424,559-$2.75M$830,601$471,764$175,993$56,168
Capital expenditure———$1———$0
Free cash flow———-$2.75M———$56,168
Investing cash flow———-$1———$0
Financing cash flow-$45,487-$206,927-$1.22M$4.47M-$74,447-$427,713-$174,004-$94,696
Depreciation & amortization$4,393$4,512$4,582$4,708$4,942$6,225$6,225$7,795
Stock-based compensation$0$314,685$123,288-$55,788$88,500$257,451$252,905—
Dividends paid$0———————

Free plan shows the latest 8 periods; Pro shows all 9 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.